NHS Test and Trace: Mass Spectrometry Pilot P2 – P3 – Market Engagement 26 November 2020

NHS Test and Trace: Mass Spectrometry Pilot P2 – P3 – Market Engagement 26 November 2020

The Department wishes to engage with the market in order to share information about potential upcoming opportunities and understand the capacity and capability of the market.

United Kingdom-London: Research laboratory services

2020/S 227-560552

Prior information notice

This notice is for prior information only

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: Department of Health and Social Care
Postal address: 39 Victoria Street
Town: London
NUTS code: UKI32 Westminster
Postal code: SW1H 0EU
Country: United Kingdom
E-mail: Hannah.Sherington@dhsc.gov.uk
Internet address(es):
Main address: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Address of the buyer profile: https://www.gov.uk/government/organisations/department-of-health-and-social-care

I.3)Communication

Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: http://health.atamis.co.uk

I.4)Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

NHS Test and Trace: Mass Spectrometry Pilot P2 – P3

 

II.1.2)Main CPV code

73111000 Research laboratory services

II.1.3)Type of contract

Services

II.1.4)Short description:

Testing for Coronavirus is a crucial part of the government’s response to the pandemic. The national Covid-19 testing strategy has pivoted toward mass population testing. To achieve this ambition a concerted effort to mobilise a range of viable testing solutions is needed. Following a feasibility study (‘P1’), the initiation of targeted pilot studies are proposed as the next step in mobilising mass spectrometry for Covid-19 testing. This PIN is for a market engagement event to understand the capacity and capability of the market for goods and services that DHSC envisions may be required under the next phases of the pilot (P2 and P3).

 

II.1.5)Estimated total value

Value excluding VAT: 2 500 000.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description

II.2.2)Additional CPV code(s)

73000000 Research and development services and related consultancy services
73111000 Research laboratory services
73111000 Research laboratory services
33140000 Medical consumables
33696500 Laboratory reagents
72300000 Data services
80420000 E-learning services
33100000 Medical equipments

II.2.3)Place of performance

NUTS code: UK UNITED KINGDOM

II.2.4)Description of the procurement:

 

The intended objectives of the programme are to support the Covid-19 testing strategy by:

• assessing and verifying that the published methods of mass spectrometry can provide a confirmatory diagnosis of patients’ infection status;

• validating that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres and validation of workflow to certain specifications (i.e. turnaround time);

• scaling methodology for mass testing with industry to support the development of end-to-end efficiencies (i.e. sample preparation through to data aggregation);

• rolling out mass spectrometry as a diagnostic tool for Covid-19 nationally across multiple regional centres. The Department of Health and Social Care (DHSC) intends to divide the procurement activity for this opportunity into contracting for the following phases:

• P2: clinical validation, maximum duration of 4 weeks;

• P3(a): scale validation, maximum duration of 12 weeks;

• P3(b): NHS scale-up, maximum duration of 4 weeks;

• P3(c): industrial scale up, duration to be confirmed The estimated value for P2 is GBP 2.5 million. DHSC intends to divide the procurement into lots based on the nature of goods or services to be provided. The scope of these individual lots is yet to be determined, but is intended to cover the following areas:

• laboratories and associated equipment for clinical validation;

• laboratories and associated equipment to build capacity;

• reagents;

• consumables;

• data transfer services (P3 only);

• eLearning for laboratory technicians.

The Department wishes to engage with the market in order to share information about potential upcoming opportunities and understand the capacity and capability of the market. Interested parties are invited to join a virtual market engagement event on 26 November 2020 where more details will be provided. When responding to this notice, please provide contact information for the representatives that you are nominating to attend the event, (maximum three per organisation). We request that organisations determine who would be best placed to attend. Responses should be sent to Hannah.Sherington@dhsc.gov.uk by 12 p.m. UK time, 25 November 2020. Please email using the subject line ‘Response to PIN — Market Engagement Event’.

 

II.2.14)Additional information

Next steps and key dates: (25 November 2020): deadline to register for the market engagement event. The agenda and protocols will be provided to all participants prior to the event. The event will be recorded for transparency and audit purposes. (26 November 20): market engagement event held. For further information or any enquiries on the above please contact Hannah.Sherington@dhsc.gov.uk

 

II.3)Estimated date of publication of contract notice:

14/12/2020

Section IV: Procedure

IV.1)Description

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.3)Additional information:

This notice is for information only, and the Department reserves the right to supplement and vary the conduct of the prior engagement process. Where this occurs, the Department will act transparently and treat all interested parties who have expressed an interest equally. The Department reserves the right to discontinue the proposed tendering process and not award any contracts pursuant to this notice. The information contained in this notice, including information relating to the nature and scope of the Department’s requirements, the service classification of this requirement or the list of CPV codes, is only indicative of the Department’s current thinking and is neither exhaustive nor binding. The Department reserves the right at its absolute discretion to amend it at the time of issue of any further notices or at any other time. The publication of this notice in no way obliges the Department to commence with any competitive tender process. The Department is not and shall not be liable for any costs incurred by those expressing any interest in participating in the market engagement exercise advertised in this notice.

 

VI.5)Date of dispatch of this notice:

17/11/2020